Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has removed a citation for a study on Duvelisib in patients with refractory indolent non-Hodgkin lymphoma, which has been replaced with the same citation without the erratum note.
    Difference
    0.4%
    Check dated 2025-05-08T13:54:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.15.0 to v2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:21:29.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant content changes, including the removal of detailed descriptions of a Phase 2 clinical trial for duvelisib in treating indolent non-Hodgkin lymphoma, while a new version number has been added.
    Difference
    18%
    Check dated 2025-04-16T20:31:01.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:00:35.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:14:30.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:17:56.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.